Why NeuroBiome for Your Practice
Deep Phenotyping
Move beyond symptom scales and conventional neurological or psychiatric parameters. NeuroBiome integrates microbiome data into a comprehensive biological profile of each patient, revealing microbial patterns that may influence neuropsychiatric conditions.
Through AI-driven microbiome modeling, our platform identifies signals relevant to the patient's clinical condition and treatment response, providing clinicians with actionable insights that support a more holistic approach to patient care through personalized treatment strategies.
AI-Driven Microbiome Modeling
Our AI platform analyzes complex microbiome patterns to identify functional imbalances and microbial signatures relevant to treatment response. This modeling approach generates clinically actionable, patient-specific microbiome insights that can support personalized therapeutic strategies.
Drug–Microbiome Interaction Insights
The gut microbiome can influence how medications are absorbed, metabolized, and tolerated, shaping individual treatment response. At the same time, many pharmacological treatments can alter microbiome composition over time, affecting gut physiology and gut–brain axis signaling.
NeuroBiome helps clinicians understand these bidirectional drug–microbiome interactions, providing microbiome-informed insights that support more personalized treatment strategies and help preserve microbiome stability during long-term therapy.
Precision Clinical Support
By integrating microbiome intelligence into clinical practice, NeuroBiome helps clinicians incorporate an additional biological layer into treatment planning, supporting more precise and individualized neuropsychiatric care.
Longitudinal Monitoring
Follow patient microbiome dynamics over time, observing real biological changes as adjuvant therapy progresses and clinical outcomes evolve.
Collaborative Platform
NeuroBiome is designed to support, not replace, clinical judgment. Our tools integrate with your workflow and expand your therapeutic toolkit.
Evidence-Based Protocols
All interventions are grounded in clinical evidence and continuously validated through our growing patient cohort database.
Designed for These Clinical Fields
Psychiatry
Neurology
The Platform at a Glance
Shotgun Metagenomics
Whole-genome sequencing of all microbial DNA in a sample. Species-level resolution across bacteria, archaea, fungi, and viruses.
ML Models
Built in house. Models trained on functional metagenomics data with neuropsychiatric outcome endpoints.
Clinical Decision Support
Structured clinical reports ranking intervention priority by predicted efficacy and drug-microbiome interactions.
Iterative Refinement
Models continuously improve through longitudinal follow-up data, increasing precision as the platform's global database expands.
Join Our Clinical Network
We are actively seeking clinical partnerships to validate our platform and expand our cohort database. Early-adopter clinicians will gain access to our full platform and contribute to shaping the future of precision neuropsychiatry.
What partnership includes:
- Full platform access for patient cohort
- Dedicated scientific support
- Co-authorship opportunities on publications
- Priority access to platform updates
Join the Early-Adopter Programme
Leave your details and we will reach out within 48 hours to schedule a discovery call and discuss how NeuroBiome can integrate into your practice.